Regulation of Mammalian mRNA Decay
哺乳动物 mRNA 衰变的调控
基本信息
- 批准号:10387387
- 负责人:
- 金额:$ 5.56万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-09-01 至 2023-02-28
- 项目状态:已结题
- 来源:
- 关键词:AddressAdenineCellsDNADiphosphatesDiseaseElementsEnzymesFlavinsFundingGene ExpressionGenetic TranscriptionGrantGuanosineHomeostasisHydrolaseIn VitroLinkMalignant NeoplasmsMessenger RNAMinorMolecularNicotinamide adenine dinucleotideNucleotidesOxidation-ReductionPost-Transcriptional RegulationProteinsProto-OncogenesRNARNA CapsRNA DecayRNA metabolismRegulationRoleStressTranslationsWorkclinical phenotypecofactorgenetic informationinsightmRNA DecaymRNA Stabilitynovel
项目摘要
Summary of the funded parental grant GM067005:
The control of mRNA stability is a critical determinant in the post-transcriptional regulation
of eukaryotic gene expression. Even minor alterations in mRNA stability can have
profound consequences and may manifest as clinical phenotypes as illustrated by the
ability of aberrantly expressed proto-oncogenes that can give rise to malignancies.
Eukaryotic mRNAs are generally thought to possess an N7 methyl guanosine (m7G) cap
at their 5¢ end to promote their stability and translation. However, our recent
demonstration that mammalian mRNAs can also carry a 5´-end nicotinamide adenine
dinucleotide (NAD) cap that in contrast to the m7G cap promotes mRNA decay, provides
a new paradigm for mRNA 5´ end processing and the contribution of nucleotide
metabolites in mRNA turnover. We now demonstrate that the redox state of NAD can also
modulate 3´ RNA decay with free NAD functioning as a cofactor to enhance RNA decay
and potentially providing a link to cellular energetics. Moreover, flavin adenine
diphosphate (FAD) can also serve as a 5´ cap on mammalian RNAs with Nudt16 and
DXO hydrolases functioning as proteins that can remove the FAD cap (deFADding) in
vitro. We will build on these novel findings throughout this proposal within three specific
aims. The first will address the functional role of free NAD on the control of 3´ end RNA
decay in vitro and delineate the molecular mechanism involved in its stimulation of decay.
The second will deduce changes in mRNA decay as a consequence of altered NAD levels
in cells and assess the regulatory role imparted by stress conditions in modulating RNA
decay through the control of NAD levels. In the last aim, we establish FAD cap as an
alternative RNA cap, identify FAD-capped RNAs and decipher the role of FAD caps and
the deFADding enzymes in cells. Collectively, the proposed studies will provide insight
into a heretofore unknown fundamental post-transcriptional regulatory mechanism and
will provide the framework for potential novel avenues to control gene expression in
normal and disease states.
资助的父母赠款GM067005的摘要:
mRNA稳定性的控制是转录后调节中的关键决定因素
真核基因表达。
深刻的后果,可能表现为临床表型表型,如你所示
异常表达的原始浓缩的能力,可能引起恶性肿瘤。
通常认为真核mRNA被认为折腾和N7甲基鸟嘌呤(M7G)帽
但是,他们的稳定性和翻译为5¢
演示Mamalian mamalian mRNA也可以携带5´-End Nicotinamide腺嘌呤
与M7G盖相反的二核苷酸(NAD)盖促进了mRNA衰变,可提供
mRNA 5´末端加工的新范式和核苷酸的贡献
mRNA周转中的代谢物。
自由nAD作为辅因子的自由NAD的模块化3´RNA衰减,以增强RNA衰减
并可能提供与细胞能量的联系
双磷酸盐(FAD)也可以用作NUDT16和NUDT16的Mamalian RNA上的5´盖
DXO水解酶作为蛋白质的作用,可以在
体外。
目标。
体外衰减并描绘出所涉及的分子机制是衰减的刺激。
由于NAD水平改变而导致mRNA衰减的第二个愿意变化
在细胞和评估中,应力条件在调节RNA中赋予的规律性作用
通过对NAD级别的控制衰减。
替代RNA盖,识别fad限制的RNA并破译时尚帽的作用和
细胞中的剥削酶。
进入迄今未知的基本转录后调节机制和
将为潜在的新型途径提供控制基因表达的框架
正常和疾病状态。
项目成果
期刊论文数量(42)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
BAY11 enhances OCT4 synthetic mRNA expression in adult human skin cells.
- DOI:10.1186/scrt163
- 发表时间:2013-02-06
- 期刊:
- 影响因子:7.5
- 作者:Awe JP;Crespo AV;Li Y;Kiledjian M;Byrne JA
- 通讯作者:Byrne JA
5' End Nicotinamide Adenine Dinucleotide Cap in Human Cells Promotes RNA Decay through DXO-Mediated deNADding.
- DOI:10.1016/j.cell.2017.02.019
- 发表时间:2017-03-09
- 期刊:
- 影响因子:64.5
- 作者:Jiao X;Doamekpor SK;Bird JG;Nickels BE;Tong L;Hart RP;Kiledjian M
- 通讯作者:Kiledjian M
The RNA binding protein HuR determines the differential translation of autism-associated FoxP subfamily members in the developing neocortex.
- DOI:10.1038/srep28998
- 发表时间:2016-07-07
- 期刊:
- 影响因子:4.6
- 作者:Popovitchenko T;Thompson K;Viljetic B;Jiao X;Kontonyiannis DL;Kiledjian M;Hart RP;Rasin MR
- 通讯作者:Rasin MR
DcpS, a general modulator of cap-binding protein-dependent processes?
- DOI:10.4161/rna.7161
- 发表时间:2008-10-01
- 期刊:
- 影响因子:4.1
- 作者:Bail, Sophie;Kiledjian, Megerditch
- 通讯作者:Kiledjian, Megerditch
DcpS as a therapeutic target for spinal muscular atrophy.
- DOI:10.1021/cb800120t
- 发表时间:2008-11-21
- 期刊:
- 影响因子:4
- 作者:Singh J;Salcius M;Liu SW;Staker BL;Mishra R;Thurmond J;Michaud G;Mattoon DR;Printen J;Christensen J;Bjornsson JM;Pollok BA;Kiledjian M;Stewart L;Jarecki J;Gurney ME
- 通讯作者:Gurney ME
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MEGERDITCH KILEDJIAN其他文献
MEGERDITCH KILEDJIAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MEGERDITCH KILEDJIAN', 18)}}的其他基金
Eukaryotic RNA NAD capping and deNADding
真核 RNA NAD 加帽和 deNADding
- 批准号:
10443996 - 财政年份:2018
- 资助金额:
$ 5.56万 - 项目类别:
Eukaryotic RNA NAD capping and deNADding
真核 RNA NAD 加帽和 deNADding
- 批准号:
10797880 - 财政年份:2018
- 资助金额:
$ 5.56万 - 项目类别:
Eukaryotic RNA NAD capping and deNADding
真核 RNA NAD 加帽和 deNADding
- 批准号:
10622526 - 财政年份:2018
- 资助金额:
$ 5.56万 - 项目类别:
相似国自然基金
以嗜热四膜虫为模式:单细胞真核生物N6-腺嘌呤甲基化遗传方式的解析
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
甲状旁腺激素通过抑制去甲基化酶ALKBH5促进非酒精性脂肪性肝纤维化形成中的作用机制研究
- 批准号:82000823
- 批准年份:2020
- 资助金额:16.0 万元
- 项目类别:青年科学基金项目
动脉粥样硬化治疗新靶点:NAD+-SIRT1信号通路调控巨噬细胞衰老
- 批准号:81900409
- 批准年份:2019
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
NOX酶活性对脊髓损伤中巨噬细胞活化的调节作用:年龄对损伤修复的影响
- 批准号:81901269
- 批准年份:2019
- 资助金额:20.5 万元
- 项目类别:青年科学基金项目
FTO介导的m6A修饰的筛选、鉴定及作为肝癌早期诊断标志物的评价
- 批准号:81902141
- 批准年份:2019
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
相似海外基金
CD38 modulation of NAD metabolism driving scleroderma pathogenesis
CD38 调节 NAD 代谢驱动硬皮病发病机制
- 批准号:
10733929 - 财政年份:2023
- 资助金额:
$ 5.56万 - 项目类别:
Soft wireless multimodal cardiac implantable devices for long-term investigating heart failure pathogenesis
用于长期研究心力衰竭发病机制的软无线多模式心脏植入装置
- 批准号:
10735395 - 财政年份:2023
- 资助金额:
$ 5.56万 - 项目类别:
Unravelling highly pathogenic influenza virus emergence
揭开高致病性流感病毒出现的谜团
- 批准号:
10718091 - 财政年份:2023
- 资助金额:
$ 5.56万 - 项目类别:
Novel Combinations of Natural Product Compounds for Treatment of Alzheimer Disease and Related Dementias
用于治疗阿尔茨海默病和相关痴呆症的天然产物化合物的新组合
- 批准号:
10603708 - 财政年份:2023
- 资助金额:
$ 5.56万 - 项目类别:
Physiology of Lifespan Extension and Metabolic Hormesis with Riboflavin Depletion
核黄素消耗延长寿命和代谢兴奋作用的生理学
- 批准号:
10663638 - 财政年份:2023
- 资助金额:
$ 5.56万 - 项目类别: